ctrl K

Price Alert

Verrica Pharmaceuticals I... (VRCA)

NASDAQ: VRCA · Real-Time Price · USD

6.15

-0.44 (-6.68%)

At close: Aug 14, 2025, 3:59 PM

6.56

6.67%

Pre-market: Aug 15, 2025, 08:00 AM EDT

Verrica Pharmaceuticals Revenue Breakdown

Period Ending	Dec 31, 2024	Dec 31, 2023
Collaboration Revenue	992K	466K
Collaboration Revenue Growth	+112.88%	n/a
Product Revenue	6.57M	4.66M
Product Revenue Growth	+41.13%	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Selling, General, and Administrative Revenue	8.85M	9.88M	16.08M	16.52M	16.34M	16.89M	20.05M	5.94M	4.32M	3.19M	3.92M	5.17M	5.12M	5.11M	8.01M	7.28M	6.58M	9.76M	4.65M	5.11M	4.99M	4.02M	3.49M	3.59M	3.54M	3.27M	3.68M	2.5M	986K	316K	238K	118K	55K
Selling, General, and Administrative Revenue Growth	-10.43%	-38.58%	-2.66%	+1.12%	-3.24%	-15.79%	+237.78%	+37.46%	+35.43%	-18.75%	-24.13%	+1.07%	+0.10%	-36.13%	+9.90%	+10.73%	-32.61%	+109.96%	-9.02%	+2.45%	+24.14%	+15.00%	-2.76%	+1.53%	+8.19%	-11.14%	+47.06%	+153.85%	+212.03%	+32.77%	+101.69%	+114.55%	n/a
Research and Development Revenue	2.28M	1.17M	2.4M	3.32M	4.95M	5.32M	6.51M	5.72M	2.74M	3.03M	2.95M	4.16M	2.72M	3.36M	3.76M	3.45M	5.36M	2.27M	4.99M	3.52M	4.89M	3.97M	3.05M	3.93M	4.49M	4.92M	3.48M	3.61M	929K	1.12M	1.12M	977K	515K
Research and Development Revenue Growth	+95.72%	-51.48%	-27.54%	-32.92%	-6.99%	-18.28%	+13.71%	+109.02%	-9.60%	+2.85%	-29.22%	+52.85%	-18.89%	-10.79%	+9.17%	-35.71%	+136.00%	-54.45%	+41.66%	-28.03%	+23.16%	+30.27%	-22.38%	-12.46%	-8.75%	+41.13%	-3.46%	+288.48%	-16.91%	-0.18%	+14.64%	+89.71%	n/a